Funding - Grants
Cancer Control and Population Sciences Home
Currently Funded HDRP Grants
Previously Funded HDRP Grants
-
All HDRP Grants
-
By RFA/PA
-
RFA
-
Office of Associate Director
-
Health Systems and Interventions Research Branch
- Accelerating Colorectal Cancer Screening and follow-up through Implementation Science (All RFAs)
- Collaborative Aging (in Place) Research Using Technology (CART) (U2C)
- Improving Outcomes for Pediatric, Adolescent and Young Adult Cancer Survivors (U01 Clinical Trial Required)
- NIH Health Care Systems Research Collaboratory - Pragmatic Clinical Trials Demonstration Projects (Uh2/Uh3)
- Research Answers to Nci's Provocative Questions (R01)
- Research Answers to Ncis Provocative Questions - Group E (R01)
- Research Answers to National Cancer Institute's (NCI) Provocative Questions (R21 Clinical Trial Optional)
- Time-Sensitive Research on Health Risk and Resilience after Hurricanes Irma and Maria in Puerto Rico and the US Virgin Islands (R21 Clinical Trial Not Allowed)
-
Healthcare Assessment Research Branch
- Population-Based Research Optimizing Screening Through Personalized Regimens (PROSPR) (U54)
- Research Centers for Population-based Research to Optimize Cancer Screening (PROSPR) Initiative (UM1)
- Statistical Coordination Center for the Population-Based Research Optimizing Screening Through Personalized Regimens (PROSPR)(U01)
-
Outcomes Research Branch
- Ancillary Domain Validation Patient-Reported Outcomes Measurement Information System (PROMIS) Studies (R01)
- Coordinating Center for Improving Management of Symptoms Across Cancer Treatments (IMPACT) (U24)
- Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21 Clinical Trial Optional)
- Development of Measures of Fatigability in Older Adults (R21)
- Person-Centered Outcomes Research Resource (U2C)
- Research Answers to National Cancer Institute's (NCI) Provocative Questions (R21 Clinical Trial Optional)
- Research Centers for Improving Management of Symptoms Across Cancer Treatments (IMPACT) (UM1)
- Research to Reduce Morbidity and Improve Care for Pediatric, and Adolescent and Young Adult (AYA) Cancer Survivors (R21 Clinical Trial Optional)
-
PA
-
Office of Associate Director
- Behavioral and Social Science Research on Understanding and Reducing Health Disparities (R21)
- Dissemination and Implementation Research in Health (All PAs)
- Improving Outcomes in Cancer Treatment-Related Cardiotoxicity (R01)
- Oral Anticancer Agents: Utilization, Adherence, and Health Care Delivery (R01 Clinical Trial Optional)
- Research Project Grant (All PAs)
-
Health Systems and Interventions Research Branch
- Advancing the Science of Geriatric Palliative Care (R21)
- Academic Research Enhancement Award (Parent R15)
- Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp)
- Behavioral and Social Science Research on Understanding and Reducing Health Disparities (All PAs)
- Cancer Surveillance Using Health Claims-Based Data System (R01)
- Change of Grantee Organization (All PAs)
- Change of Recipient Organization (Type 7 Parent Clinical Trial Optional)
- Dissemination and Implementation Research in Health (All PAs)
- Exploratory Grants for Behavioral Research in Cancer Control (R21)
- Ethical, Legal, and Social Implications (ELSI) of Genomics Exploratory/Developmental Research Grant Program (R21)
- Examination of Survivorship Care Planning Efficacy and Impact (All PAs)
- Improving Patient Adherence to Treatment and Prevention Regimens to Promote Health (R21 Clinical Trial Optional)
- Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R03 Clinical Trial Optional)
- Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (All PAs)
- Multilevel Interventions in Cancer Care Delivery: Building From the Problem of Follow-Up to Abnormal Screening Tests (U01)
- Methodology and Measurement in the Behavioral and Social Sciences (R21)
- Multilevel Interventions in Cancer Care Delivery: Building from the Problem of Follow-up to Abnormal Screening Tests (U01)
- NCI Exploratory/Developmental Research Grant Program (All PAs)
- NCI Research Specialist Award (R50)
- NCI Small Grants Program for Cancer Research (All PAs)
- NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)
- NIH Support for Conferences and Scientific Meetings (All PAs)
- NSF/NIH Smart and Connected Health Program (R01)
- National Cancer Institute Program Project Applications (P01 Clinical Trial Optional)
- Research on the Health of Lgbti Populations (R21)
- Research Project Grant (All PAs)
- Research to Characterize and Reduce Stigma to Improve Health (R03)
- Reducing Overscreening for Breast, Cervical, and Colorectal Cancers among Older Adults (R21 Clinical Trial Optional)
- Research Supplements to Promote Diversity in Health-Related Research (Admin Supp Clinical Trial Not Allowed)
- Research on the Health of Transgender and Gender Nonconforming Populations (R21 Clinical Trial Optional)
- Small Grants for Behavioral Research in Cancer Control (All PAs)
- Social Network Analysis and Health (R01)
- Stimulating Innovations in Behavioral Intervention Research for Cancer Prevention and Control (R21 Clinical Trial Optional)
- Systems Science and Health in the Behavioral and Social Sciences (R21)
- The Effect of Racial and Ethnic Discrimination/Bias on Health Care Delivery (All PAs)
- The Health of Sexual and Gender Minority (All PAs)
- Translating Basic Behavioral and Social Science Discoveries into Interventions to Improve Health-Related Behaviors (R01)
- Understanding and Promoting Health Literacy (R21)
- Using Information Technology to Support Systematic Screening and Treatment of Depression in Cancer (R21 Clinical Trial Optional)
-
Healthcare Assessment Research Branch
- Academic Research Enhancement Award (Parent R15)
- Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Admin Supp)
- Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp - Clinical Trial Optional)
- Behavioral and Social Science Research on Understanding and Reducing Health Disparities (R21)
- Cancer Surveillance Using Health Claims-Based Data System (All PAs)
- Change of Grantee Organization (Type 7 Parent)
- Change of Recipient Organization (Type 7 Parent Clinical Trial Optional)
- Dissemination and Implementation Research in Health (All PAs)
- Ethical, Legal, and Social Implications (ELSI) of Genomic Research Regular Research Program (R01)
- Exploratory Grants for Behavioral Research in Cancer Control (R21)
- Exploratory/Developmental Surgical Disparities Research (R21 Clinical Trial Optional)
- Methodology and Measurement in the Behavioral and Social Sciences (R21)
- Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional)
- NCI Exploratory/Developmental Research Grant Program (All PAs)
- NCI Research Specialist (All PAs)
- NCI Small Grants Program for Cancer Research (All PAs)
- NCI Small Grants Program for Cancer Research for Years 2020, 2021, and 2022 (NCI Omnibus R03 Clinical Trial Optional)
- Oral Anticancer Agents: Utilization, Adherence, and Health Care Delivery (R21 Clinical Trial Optional)
- Research Project Grant (All PAs)
- Small Grants for Behavioral Research in Cancer Control (R03)
- Surgical Disparities Research (R01 Clinical Trial Optional)
-
Outcomes Research Branch
- Academic Research Enhancement Award (Parent R15)
- Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp - Clinical Trial Optional)
- Behavioral and Social Science Research on Understanding and Reducing Health Disparities (R21)
- Change of Recipient Organization (Type 7 Parent Clinical Trial Optional)
- Dissemination and Implementation Research in Health (R21)
- Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)
- End-of-Life and Palliative Needs of Adolescents and Young Adults (All PAs)
- Examination of Survivorship Care Planning Efficacy and Impact (R21)
- Examination of Survivorship Care Planning Efficacy and Impact [R21]
- Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)
- Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (All PAs)
- Mechanisms, Models, Measurement, & Management in Pain Research (R21)
- Methodology and Measurement in the Behavioral and Social Sciences (All PAs)
- Methodology and Measurement in the Behavioral and Social Sciences (R21)
- Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional)
- NCI Exploratory/Developmental Research Grant Program (All PAs)
- NCI Outstanding Investigator Award (R35)
- NCI Small Grants Program for Cancer Research (All PAs)
- NCI Small Grants Program for Cancer Research for Years 2020, 2021, and 2022 (NCI Omnibus R03 Clinical Trial Optional)
- NIH Pathway to Independence Award (Parent K99/R00 - Independent Clinical Trial Not Allowed)
- NIH Research Project Grant (All PAs)
- NIH Support for Conferences and Scientific Meetings (All PAs)
- Oral Anticancer Agents: Utilization, Adherence, and Health Care Delivery (R21 Clinical Trial Optional)
- Research on Clinical Decision Making in People with or at Risk for Life-Threatening Illness (R01)
- Research on the Health of Lgbti Populations (R21)
- Research on the Health of Lgbti Populations [R01]
- Research Project Grant (All PAs)
- Research Supplements to Promote Diversity in Health-Related Research (Admin Supp Clinical Trial Not Allowed)
- Small Grants for Behavioral Research in Cancer Control (All PAs)
- Stimulating Innovations in Behavioral Intervention Research for Cancer Prevention and Control (R21)
-
| Grant Status | Currently Funded |
| Division | Division of Cancer Control and Population Sciences |
| Program | Healthcare Delivery Research Program (HDRP) |
| Branch | Office of Associate Director |
| Initiatives |
|
| PI Name | Organization Name | Project Title (Click for Abstract, Pubs, etc.) |
Grant Number | Awarded Dollars | Fiscal Year | Abstract Page URL |
|---|---|---|---|---|---|---|
| Wolfson, Julie Anna | University of Alabama at Birmingham | Predictors of Systemic Exposure to Oral 6mp During Maintenance in Adolescentsand Young Adults with Acute Lymphoblastic Leukemia | 5R01CA248439-05 | 540972 | 2025 | https://maps.cancer.gov/overview/DCCPSGrants/abstract.jsp?applId=11054646&term=CA248439 |